T. Rowe Price (TROW) Stock Sinks As Market Gains: What You Should Know

T. Rowe Price (TROW) shares underperformed the S&P 500 and its sector over the past month, closing down 1.54% in the latest session. Analysts anticipate an 11.95% year-over-year decline in earnings per share to $1.99 for the upcoming earnings disclosure, with revenue expected to decrease by 2.16% to $1.7 billion. The stock currently holds a Zacks Rank #4 (Sell), with a Forward P/E ratio of 11.33 and a PEG ratio of 3.04, signaling a premium valuation compared to its industry; analysts have increased estimates by 0.57% over the last 30 days.

Analysis

T. Rowe Price (TROW) recently closed at $92.15, reflecting a 1.54% decline, underperforming the S&P 500's 0.41% gain on the same day. Over the past month, TROW's 2.12% gain also lagged both the Finance sector's 4.15% increase and the S&P 500's 6.13% rise, indicating relative weakness. Analysts project a challenging near-term outlook, with consensus estimates for the upcoming earnings report pointing to earnings of $1.99 per share, an 11.95% year-over-year decrease, and revenue of $1.7 billion, down 2.16% from the prior year. Full-year fiscal estimates also anticipate declines, with earnings per share expected at $8.26 (-11.47% YoY) and revenue at $6.92 billion (-2.5% YoY). Despite these negative projections, the Zacks Consensus EPS estimate has seen a minor positive revision of 0.57% over the last 30 days. However, TROW currently holds a Zacks Rank #4 (Sell). Valuation metrics also warrant attention: its Forward P/E ratio of 11.33 is a premium to its industry's average of 10.74, and its PEG ratio of 3.04 is substantially higher than the industry average of 1.3, suggesting the stock may be overvalued relative to its growth prospects. The Financial - Investment Management industry itself is positioned in the bottom 12% of all industries according to the Zacks Industry Rank, further highlighting potential headwinds.

Key Decisions for Investors

• Given T. Rowe Price's recent market underperformance, anticipated declines in earnings and revenue, a Zacks Rank #4 (Sell), and premium valuation metrics (Forward P/E of 11.33 and PEG of 3.04), investors should exercise caution and re-evaluate their positions.
• Investors should closely monitor the upcoming earnings disclosure for any deviation from the expected 11.95% YoY EPS decline and 2.16% YoY revenue decrease, as this will be a key catalyst for the stock.
• Pay attention to any further shifts in analyst EPS estimates, as the recent 0.57% upward revision, though small, could signal evolving near-term business trends despite the overall negative sentiment and weak industry ranking.